S 1095 ยท Stop STALLING Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.
- Introduced
- Mar 24, 2025
- Latest action
- Apr 10, 2025
- Sponsor
- Sen. Amy Klobuchar [D-MN]
- Policy area
- Health
- Cosponsors
- 6
Summary
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit is subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Recent actions
- Apr 10, 2025 Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.
- Apr 10, 2025 Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
- Apr 10, 2025 Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
- Apr 3, 2025 Committee on the Judiciary. Ordered to be reported without amendment favorably.
- Mar 24, 2025 Read twice and referred to the Committee on the Judiciary.
- Mar 24, 2025 Introduced in Senate
Votes
No recorded votes are available for this bill.